Detalles de la búsqueda
1.
Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence.
Diabetes Obes Metab
; 26(5): 1555-1566, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38263540
2.
Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.
Diabetes Obes Metab
; 23(9): 2090-2098, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34047449
3.
Advanced decision support system for individuals with diabetes on multiple daily injections therapy using reinforcement learning and nearest-neighbors: In-silico and clinical results.
Artif Intell Med
; 148: 102749, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38325921
4.
Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin Therapy in Adults With Suboptimally Controlled Type 1 Diabetes: A Randomized Crossover Controlled Trial.
Diabetes Care
; 46(1): 165-172, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331522
5.
A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
Diabetes Care
; 46(7): 1372-1378, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37134305
6.
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.
Nat Med
; 28(6): 1269-1276, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35551290
7.
Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach.
Comput Methods Programs Biomed
; 200: 105936, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515844
Resultados
1 -
7
de 7
1
Próxima >
>>